Which drugs does patent 7,396,841 protect, and when does it expire?
Patent 7,396,841 protects PREVACID IV and is included in one NDA.
Protection for PREVACID IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has expired prematurely due to non-payment of maintenance fees. See details below.